Advisory Committee on Immunization Practices: Meeting, 33456-33457 [E6-8994]

Download as PDF 33456 Federal Register / Vol. 71, No. 111 / Friday, June 9, 2006 / Notices to its beneficiaries in a financially sustainable way. DATES: The Meeting: July 11–12, 2006. The meeting will begin at 9 a.m. on July 11, and 8:30 a.m. on July 12. Special Accommodations: Persons attending the meeting who are hearing or visually impaired, or have a condition that requires special assistance or accommodations, are asked to notify the Medicaid Commission by June 30, 2006 (see FOR FURTHER INFORMATION CONTACT). ADDRESSES: The Meeting: The meeting will be held at the following address: Sheraton Crystal City, 1800 Jefferson Davis Highway, Arlington, Virginia 22202, United States, telephone: (703) 486–1111, fax: (703) 769–3970. Web site: You may access up-to-date information on the Medicaid Commission at https://aspe.hhs.gov/ medicaid/. FOR FURTHER INFORMATION CONTACT: Margaret Reiser, (202) 205–8255. SUPPLEMENTARY INFORMATION: On May 24, 2005, we published a notice (70 FR 29765) announcing the Medicaid Commission and requesting nominations for individuals to serve on the Medicaid Commission. This notice announces a public meeting of the Medicaid Commission. Topics of the Meeting The Commission will discuss options for making longer-term recommendations on the future of the Medicaid program that ensure long-term sustainability. Issues to be addressed may include, but are not limited to: Eligibility, benefit design, and delivery; expanding the number of people covered with quality care while recognizing budget constraints; long term care; quality of care, choice, and beneficiary satisfaction; and program administration. jlentini on PROD1PC65 with NOTICES Procedure and Agenda This meeting is open to the public. There will be a public comment period at the meeting. The Commission may limit the number and duration of oral presentations to the time available. We will request that you declare at the meeting whether or not you have any financial involvement related to any services being discussed. After the presentations and public comment period, the Commission will deliberate openly. Interested persons may observe the deliberations, but the Commission will not hear further comments during this time except at the request of the Chairperson. The Commission will also allow an open VerDate Aug<31>2005 16:01 Jun 08, 2006 Jkt 208001 public session for any attendee to address issues specific to the topic. Authority: 5 U.S.C. App. 2, 10(a)(1) and (a)(2). Dated: June 2, 2006. Donald A. Young, Acting Assistant Secretary for Planning and Evaluation, Department of Health and Human Services. [FR Doc. E6–8993 Filed 6–8–06; 8:45 am] BILLING CODE 5150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Targeted Evaluation of the President’s Emergency Plan for AIDS Relief (PEPFAR) Funded Prevention of Mother-to-Child HIV Transmission (PMTCT), and Adherence to Antiretroviral Therapy (ART) Programs, Contract Solicitation Numbers (CSN) 2006–N–08428, 2006–N–08429, and 2006–N–08430 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Targeted Evaluation of the President’s Emergency Plan for AIDS Relief (PEPFAR) Funded Prevention of Mother-toChild HIV Transmission (PMTCT), and Adherence to Antiretroviral Therapy (ART) Programs, Contract Solicitation Numbers (CSN) 2006–N–08428, 2006–N–08429, and 2006–N–08430. Time and Date: 8:30 a.m.–9 a.m., June 27, 2006 (Open). 9 a.m.–6 p.m., June 27, 2006 (Closed). Place: Renaissance Concourse Hotel— Marriott, One Hartsfield Center Parkway, Atlanta, GA 30354, Telephone 404–209– 9999. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to ‘‘Targeted Evaluation of the PEPFAR Funded PMTCT, and ART Programs,’’ Contract Solicitation Numbers (CSN) 2006–N–08428, 2006–N–08429, and 2006–N–08430. For Further Information Contact: Amy L. Sandul, Health Scientist, National Center for HIV, STD, and Tuberculosis Prevention, Centers for Disease Control and Prevention, PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 1600 Clifton Road NE., MS E–41, Atlanta, GA 30333, Telephone 404.639.6485. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 2, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–8991 Filed 6–8–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Immunization Practices: Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following Federal Committee meeting. Name: Advisory Committee on Immunization Practices (ACIP). Time and Date: 8 a.m.–6 p.m., June 29, 2006. 8 a.m.–4 p.m., June 30, 2006. Place: Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Building 19, Room 232, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The Committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Matters to be Discussed: The agenda will include discussions on Human Papillomavirus Vaccine, which will include a VFC Vote; Varicella Virus Vaccine, which will include a VFC Vote; Influenza Vaccine; Mumps Outbreak; Use of Tdap in pregnant women; Adult Immunization Schedule; Pneumococcal Vaccine; Herpes zoster (Shingles) Vaccine; Childhood/Adolescent Immunization Schedule; Immunization Safety; Menactra Supply and Prioritization; Update on Rotavirus Vaccine; and Agency updates. Agenda items are subject to change as priorities dictate. For Further Information Contact: Demetria Gardner, Epidemiology and Surveillance Division, National Immunization Program, CDC, 1600 Clifton Road, NE., (E–61), Atlanta, Georgia 30333, telephone 404/639–8096, fax 404/639–8616. E:\FR\FM\09JNN1.SGM 09JNN1 Federal Register / Vol. 71, No. 111 / Friday, June 9, 2006 / Notices The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR. Dated: June 2, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–8994 Filed 6–8–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare and Medicaid Services [Document Identifier: CMS–10195] Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget (OMB) Center for Medicare and Medicaid Services. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare and Medicaid Services (CMS), Department of Health and Human Services, is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. We are, however, requesting an emergency review of the information collection referenced below. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, we have submitted to the Office of Management and Budget (OMB) the following requirements for emergency review. We are requesting an emergency review because the collection of this information is needed before the expiration of the normal time limits under OMB’s regulations at 5 CFR part 1320. This is necessary to ensure compliance with an initiative of the jlentini on PROD1PC65 with NOTICES AGENCY: VerDate Aug<31>2005 16:01 Jun 08, 2006 Jkt 208001 Administration. We cannot reasonably comply with the normal clearance procedures because of an unanticipated event. The purpose of the Medicare Recovery Audit Contractor (RAC) Demonstration Project is to evaluate the cost and savings to the Medicare program and to make appropriate recommendations to Congress on the cost-effectiveness of extending or expanding the project. Because RACs have been used successfully in nonMedicare markets, The Centers for Medicare and Medicaid Services (CMS) is conducting this demonstration project to test new techniques for identifying and collecting overpayments. This is a request for OMB approval of a Provider Satisfaction Survey to assess the impact of Medicare Recovery Audit Contractors (RACs) on the provider community. The Centers for Medicare and Medicaid Services (CMS) has contracted with Econometrica, Inc. to conduct an independent evaluation of the Medicare RAC demonstration. The results, which will be summarized in a report to Congress, will be used to assess the financial impact of the demonstration on the Medicare program and to make recommendations for the demonstration’s extension or expansion. Previous research by the U.S. Government Accountability Office found that RACs have the potential to burden private providers. The purpose of this study is to determine whether RACs can perform effectively with a low risk of burden and friction with healthcare providers. 1. Type of Information Collection Request: New collection; Title of Information Collection: Evaluation of Medicare Recovery Audit Contractor (RAC) Demonstration Provider Satisfaction Survey; Use: The purpose of the RAC Provider Satisfaction Survey is to gauge provider communications and satisfaction with the RACs. Measuring providers’ reactions to and experiences with RACs will enable CMS better understand the potential impact of the RACs on providers nationwide and to improve and refine the process, both in the context of the current demonstration as well as in future reform initiatives. The survey will cover all aspects of provider transactions with RACs. Form Number: CMS–10195 (OMB#: 0938– NEW); Frequency: Reporting—One-time; Affected Public: Business or other forprofit; Number of Respondents: 1,200; Total Annual Responses: 1,200; Total Annual Hours: 276. CMS is requesting OMB review and approval of this collection by July 7, 2006, with a 180-day approval period. Written comments and recommendation PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 33457 will be considered from the public if received by the individuals designated below by July 3, 2006. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, access CMS’ Web site address at https://www.cms.hhs.gov/ regulations/pra or E-mail your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call the Reports Clearance Office on (410) 786–1326. Interested persons are invited to send comments regarding the burden or any other aspect of these collections of information requirements. However, as noted above, comments on these information collection and recordkeeping requirements must be mailed and/or faxed to the designees referenced below by July 3, 2006: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development—B, Attn: William N. Parham, III, Room C4–26– 05, 7500 Security Boulevard, Baltimore, MD 21244–1850, and OMB Human Resources and Housing Branch, Attention: Carolyn Lovett, New Executive Office Building, Room 10235, Washington, DC 20503. Fax Number: (202) 395–6974. Dated: May 26, 2006. Michelle Shortt, Director, Regulations Development Group, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 06–5134 Filed 6–1–06; 2:37 pm] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10069, CMS– 10137, CMS–1763 and CMS–10080] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services, is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this AGENCY: E:\FR\FM\09JNN1.SGM 09JNN1

Agencies

[Federal Register Volume 71, Number 111 (Friday, June 9, 2006)]
[Notices]
[Pages 33456-33457]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-8994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal Committee meeting.

    Name: Advisory Committee on Immunization Practices (ACIP).
    Time and Date: 8 a.m.-6 p.m., June 29, 2006. 8 a.m.-4 p.m., June 
30, 2006.
    Place: Centers for Disease Control and Prevention, 1600 Clifton 
Road, NE., Building 19, Room 232, Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters to be Discussed: The agenda will include discussions on 
Human Papillomavirus Vaccine, which will include a VFC Vote; 
Varicella Virus Vaccine, which will include a VFC Vote; Influenza 
Vaccine; Mumps Outbreak; Use of Tdap in pregnant women; Adult 
Immunization Schedule; Pneumococcal Vaccine; Herpes zoster 
(Shingles) Vaccine; Childhood/Adolescent Immunization Schedule; 
Immunization Safety; Menactra Supply and Prioritization; Update on 
Rotavirus Vaccine; and Agency updates. Agenda items are subject to 
change as priorities dictate.
    For Further Information Contact: Demetria Gardner, Epidemiology 
and Surveillance Division, National Immunization Program, CDC, 1600 
Clifton Road, NE., (E-61), Atlanta, Georgia 30333, telephone 404/
639-8096, fax 404/639-8616.

[[Page 33457]]

    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the CDC and ATSDR.

    Dated: June 2, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E6-8994 Filed 6-8-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.